National Syndromic Surveillance Program Public Comment Period
The Centers for Disease Control and Prevention (CDC) announced the closure of the public comment period for the National Syndromic Surveillance Program (NSSP). The comment period ended on February 5, 2025. This notice serves as an update on the status of the program's public consultation phase.
USPTO Grants Patent for Single Molecule Peptide Sequencing
The USPTO has granted a patent (US12578345B2) to The University of Texas System for methods of single molecule peptide sequencing. The patent covers techniques for identifying polypeptide sequences within a mixture by immobilizing, labeling, and analyzing the polypeptide.
USPTO Patent for Alzheimer's Detection Kits
The USPTO has granted a patent (US12578344B2) to NEUROQUEST LTD. for compositions, kits, and methods for detecting preclinical Alzheimer's Disease. The patent covers binding agents for biomarkers such as CD163 and scavenger receptors, and methods for diagnosing AD and assessing therapeutic efficacy.
USPTO Patent Grant: Canine TK1 Protein Determination Kit
The USPTO has granted patent US12578340B2 to ALERTIX VETERINARY DIAGNOSTICS AB for a kit to determine canine TK1 protein levels. The kit utilizes specific monoclonal antibodies to detect peptides from canine TK1.
USPTO Patent Grant for Polypeptide Reagent Kit
The USPTO has granted a patent (US12578329B2) to Shimadzu Corporation for a reagent kit containing polypeptides designed for detecting intermolecular interactions. The patent details specific amino acid sequences and their modifications for use in this kit.
Microsoft Technology Licensing, LLC Awarded Patent for Anti-lock Hinged Device
The USPTO has granted Microsoft Technology Licensing, LLC a patent for an anti-lock hinged device. The patent, US12577979B2, describes a mechanism designed to prevent over-extension in hinged devices. The filing date for this patent application was October 23, 2023.
USPTO Patent Grant US12581852B2 for Luminescent Material
The United States Patent and Trademark Office (USPTO) has granted patent US12581852B2 to KYULUX, INC. for a compound useful as a light-emitting material. The patent covers specific chemical formulas and their application in organic optical devices.
Samsung Display Patent for Organic Compound Sensor Display
The USPTO has granted Samsung Display Co., Ltd. a patent for an organic compound sensor display. The patent, US12581853B2, covers an organic compound represented by Chemical Formula 1 and its application in sensor-embedded display panels and electronic devices. The filing date was September 28, 2022.
USPTO Patent Grant for Light-Emitting Element
The USPTO has granted patent US12581794B2 for a light-emitting element developed by Semiconductor Energy Laboratory Co., Ltd. The patent covers a specific design for a light-emitting element utilizing a phosphorescent compound and an exciplex formed by organic compounds.
USPTO Patent Grant: Bioprobes for Amine Oxidase Enzymes
The USPTO has granted a patent (US12578335B2) to Syntara Limited for novel bioprobes designed to detect and quantify amine oxidase enzymes. These bioprobes are intended for use in assessing enzyme concentrations and inhibition levels in various samples.
USPTO Grants Bone Conduction Device Patent to Cochlear Limited
The USPTO has granted a patent (US12581254B2) to Cochlear Limited for a bone conduction device. The patent covers an external component with a quick-connect feature for a vibrator and platform, designed to transfer vibrations to the recipient's skin. The patent was granted on March 17, 2026.
USPTO Patent US12579812B2: Tip type verification using image processing
The USPTO has granted patent US12579812B2 to Johnson & Johnson Surgical Vision, Inc. for a method of verifying the tip type of an ophthalmic instrument using image processing. The patent describes a system that acquires an image of the tip, identifies its visual properties, and compares them to stored definitions to ensure the correct tip type is selected for a medical procedure.
USPTO Patent US12578700B2: 3D Printing Microstructures File Format
The USPTO has granted patent US12578700B2 to OPT Industries, Inc. for systems, methods, and a new file format for 3D printing microstructures. The patent describes a wireframe model expressed as a collection of wires for defining 3D objects, enabling the printing of novel items like eyelashes and swabs.
USPTO Patent Grant US12578593B2: Spiral Dioptre
The USPTO has granted patent US12578593B2 for a spiral dioptre with meridians of different optical power, assigned to SPIRAL. This patent relates to optical devices designed to provide a focused tubular region.
USPTO Patent Grant: Sag Compensation Deformable Lens
The USPTO has granted Apple Inc. a patent (US12578511B1) for a sag compensation structure for deformable lenses. This structure aims to mitigate gravity-induced sag in deformable lens membranes, potentially improving optical performance in lens assemblies.
Sumitomo Pharma Design Patent Grant for Dish
The USPTO has granted a design patent (USD1118970S1) for a dish to Sumitomo Pharma Co., Ltd., with an effective date of March 17, 2026. The patent covers a specific design related to diagnostic or surgical applications, as indicated by its CPC classifications.
USPTO Grants Medical Instrument Patent to Shanghai United Imaging
The USPTO has granted a design patent (USD1118971S1) for a medical instrument to Shanghai United Imaging Microelectronics Technology Co., Ltd. The patent covers a design related to diagnosis and surgery, with a filing date of August 21, 2024.
USPTO Patent Grant for Mint Labs Inc. Tractography Image Diagnosis Methods
The USPTO has granted a patent to Mint Labs Inc. for systems and methods to improve tractography images used in diagnosing neurodegenerative diseases. The patent, Reissue USRE050823E1, focuses on enhancing diffusion-based magnetic resonance imaging for damaged nervous systems, potentially serving as a biomarker for patient assessment.
USPTO Patent Grant: Depilatory Device
The United States Patent and Trademark Office (USPTO) has granted a design patent for a depilatory device. The patent, identified as USD1119080S1, was granted on March 17, 2026, to inventor Kai Dou. This grant signifies the protection of the unique design of the device.
USPTO Grants Design Patent for Mouthguard
The USPTO has granted a design patent (USD1119093S1) for a mouthguard to DCSTAR INC. The patent covers the ornamental design of the mouthguard, with a filing date of January 27, 2025, and an issue date of March 17, 2026. This grant signifies a new intellectual property right for the assignee.
USPTO Patent Grant: Diagnostic Antibodies Against MUC17
The USPTO has granted patent US12577322B2 to Amgen Inc. for diagnostic antibodies against mucin 17 (MUC17). These antibodies and associated detection systems are intended for detecting, quantifying, and monitoring MUC17 related to disease diagnosis, progression, and therapeutic response.
USPTO Patent Grant for Bispecific Antibodies
The USPTO has granted a patent (US12577314B2) to ABL BIO INC. for bispecific antibodies designed to treat diseases related to BCMA and/or 4-1BB proteins. The patent covers the antibody's structure and its therapeutic applications.
US Patent 12577313B2 for Bispecific Antibodies
The USPTO has granted US Patent 12577313B2 for bispecific antibodies targeting claudin 18.2 and 4-1BB, assigned to I-Mab Biopharma US Limited. The patent covers novel antibody designs that can trigger tumor-specific immune responses.
Anti-CSF1R Antibodies and Pharmaceutical Compositions Patent
The USPTO has granted patent US12577309B2 for anti-CSF1R antibodies, pharmaceutical compositions, and their uses. The patent was assigned to DRAGONBOAT BIOPHARMACEUTICAL (SHANGHAI) CO., LTD. and lists six inventors. The patent's abstract describes antibodies against human CSF-1R.